Like the situation in bladder cancer, presence of HER4 expression was also independent predictor of favored outcome in breast cancer and the head and neck squamous cell carcinoma (Barnes et al., 2005; Machleidt et al., 2013; De Pauw et al., 2018). This evidence concerns the gene ERBB4 and urinary bladder cancer.